Spremljaj
Mehrdad Hashemi
Mehrdad Hashemi
Professor
Preverjeni e-poštni naslov na iautmu.ac.ir
Naslov
Navedeno
Navedeno
Leto
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
MDA Paskeh, M Entezari, S Mirzaei, A Zabolian, H Saleki, MJ Naghdi, ...
Journal of hematology & oncology 15 (1), 83, 2022
3752022
Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases
A Bolhassani, S Javanzad, T Saleh, M Hashemi, MR Aghasadeghi, ...
Human vaccines & immunotherapeutics 10 (2), 321-332, 2014
3312014
AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation
M Entezari, D Hashemi, A Taheriazam, A Zabolian, S Mohammadi, ...
Biomedicine & Pharmacotherapy 146, 112563, 2022
2372022
Anticancer activity of curcumin on human breast adenocarcinoma: Role of Mcl-1 gene
ZK Koohpar, M Entezari, A Movafagh, M Hashemi
Iranian journal of cancer prevention 8 (3), e2331, 2015
1372015
Molecular landscape of LncRNAs in prostate cancer: a focus on pathways and therapeutic targets for intervention
S Mirzaei, MDA Paskeh, E Okina, MH Gholami, K Hushmandi, M Hashemi, ...
Journal of Experimental & Clinical Cancer Research 41 (1), 214, 2022
1262022
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response
M Sadrkhanloo, M Entezari, S Orouei, M Ghollasi, S Rezaei, ES Hejazi, ...
Pharmacological research 182, 106311, 2022
1232022
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
M Ashrafizadeh, MDA Paskeh, S Mirzaei, MH Gholami, A Zarrabi, ...
Journal of Experimental & Clinical Cancer Research 41 (1), 105, 2022
1202022
Role of microRNA/epithelial-to-mesenchymal transition axis in the metastasis of bladder cancer
M Ashrafizadeh, K Hushmandi, M Hashemi, ME Akbari, P Kubatka, ...
Biomolecules 10 (8), 1159, 2020
1132020
Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy
M Hashemi, MS Moosavi, HM Abed, M Dehghani, M Aalipour, EA Heydari, ...
Pharmacological research 184, 106418, 2022
1102022
DNA adducts with antioxidant flavonoids: morin, apigenin, and naringin
S Nafisi, M Hashemi, M Rajabi, HA Tajmir-Riahi
Dna and cell biology 27 (8), 433-442, 2008
1092008
Study on clinical and biochemical toxicity biomarkers in a zinc-lead mine workers
AA Malekirad, S Oryan, A Fani, V Babapor, M Hashemi, M Baeeri, ...
Toxicology and industrial health 26 (6), 331-337, 2010
1082010
EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
M Hashemi, HZ Arani, S Orouei, S Fallah, A Ghorbani, M Khaledabadi, ...
Biomedicine & Pharmacotherapy 155, 113774, 2022
1012022
(Nano) platforms in bladder cancer therapy: Challenges and opportunities
M Ashrafizadeh, A Zarrabi, H Karimi‐Maleh, A Taheriazam, S Mirzaei, ...
Bioengineering & translational medicine 8 (1), e10353, 2023
992023
(Nano) platforms in breast cancer therapy: drug/gene delivery, advanced nanocarriers and immunotherapy
M Ashrafizadeh, A Zarrabi, A Bigham, A Taheriazam, Y Saghari, S Mirzaei, ...
Medicinal Research Reviews 43 (6), 2115-2176, 2023
922023
A cancer-array approach elucidates the immune escape mechanism and defects in the DNA repair system in esophageal squamous cell carcinoma
E Dadkhah, H Naseh, M Farshchian, B Memar, M Sankian, R Bagheri, ...
Archives of Iranian medicine 16 (8), 0-0, 2013
922013
Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling
M Entezari, M Ghanbarirad, A Taheriazam, M Sadrkhanloo, A Zabolian, ...
Biomedicine & Pharmacotherapy 150, 112963, 2022
882022
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: promises and challenges
MDA Paskeh, F Ghadyani, M Hashemi, A Abbaspour, A Zabolian, ...
Pharmacological research 187, 106553, 2023
812023
Analysis of the antiproliferative effects of curcumin and nanocurcumin in MDA-MB231 as a breast cancer cell line
MH Khosropanah, A Dinarvand, A Nezhadhosseini, A Haghighi, ...
Iranian journal of pharmaceutical research: IJPR 15 (1), 231, 2016
812016
The role of microRNAs in different types of thyroid carcinoma: a comprehensive analysis to find new miRNA supplementary therapies
S Pishkari, M Paryan, M Hashemi, E Baldini, S Mohammadi-Yeganeh
Journal of endocrinological investigation 41, 269-283, 2018
792018
Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions
M Hashemi, S Etemad, S Rezaei, S Ziaolhagh, R Rajabi, P Rahmanian, ...
Biomedicine & Pharmacotherapy 158, 114204, 2023
782023
Sistem trenutno ne more izvesti postopka. Poskusite znova pozneje.
Članki 1–20